ArticleNPJ breast cancer2021

Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study.

Ioannis Zerdes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.